Search research articles
Contact Us
Filters
Showing results (21-30 of 66) with videos related to
Page
of 7
Sort By:
Pharmacotherapy
|
October 20, 2005
Antiplatelet drug resistance: not ready for prime time
Tammy L Burns, Aryan N Mooss, Daniel E Hilleman
Southern Medical Journal
|
April 3, 2024
Elevated Lp(a): Guidance for Identifying and Managing Patients
Daniel E Hilleman, James L Vacek, James M Backes
Chest
|
February 11, 2004
Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery
Daniel E Hilleman, Syed M Mohiuddin, Kathleen A Packard
Pharmacotherapy
|
June 26, 2010
Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers
Estella M Davis, Kathleen A Packard, Daniel E Hilleman
Pharmacotherapy
|
February 18, 2003
Reteplase for dysfunctional hemodialysis catheter clearance
Daniel E Hilleman, Robert W Dunlay, Kathleen A Packard
Pharmacotherapy
|
September 2, 2004
Cost of a pharmacist-directed intervention to increase treatment of hypercholesterolemia
Daniel E Hilleman, Michele A Faulkner, Michael S Monaghan
Advances in Therapy
|
January 11, 2020
Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review
Daniel E Hilleman, Barbara S Wiggins, Michael B Bottorff
Postgraduate Medicine
|
October 6, 2025
A narrative review of drugs targeting inflammation in vascular disease
Jenna Kristan, Mark A Malesker, James M Backes, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
July 2, 2019
Alpha-1 Antitrypsin Replacement in Patients With COPD
Adam D Wells, Anna Woods, Daniel E Hilleman, et al.
COPD
|
April 26, 2011
Economic evaluation of a disease management program for chronic obstructive pulmonary disease
Naresh A Dewan, Kathryn L Rice, Michael Caldwell, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 66) with videos related to
Sort By:
Page
of 7
Pharmacotherapy
|
October 20, 2005
Antiplatelet drug resistance: not ready for prime time
Tammy L Burns, Aryan N Mooss, Daniel E Hilleman
Southern Medical Journal
|
April 3, 2024
Elevated Lp(a): Guidance for Identifying and Managing Patients
Daniel E Hilleman, James L Vacek, James M Backes
Chest
|
February 11, 2004
Comparison of conservative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery
Daniel E Hilleman, Syed M Mohiuddin, Kathleen A Packard
Pharmacotherapy
|
June 26, 2010
Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers
Estella M Davis, Kathleen A Packard, Daniel E Hilleman
Pharmacotherapy
|
February 18, 2003
Reteplase for dysfunctional hemodialysis catheter clearance
Daniel E Hilleman, Robert W Dunlay, Kathleen A Packard
Pharmacotherapy
|
September 2, 2004
Cost of a pharmacist-directed intervention to increase treatment of hypercholesterolemia
Daniel E Hilleman, Michele A Faulkner, Michael S Monaghan
Advances in Therapy
|
January 11, 2020
Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review
Daniel E Hilleman, Barbara S Wiggins, Michael B Bottorff
Postgraduate Medicine
|
October 6, 2025
A narrative review of drugs targeting inflammation in vascular disease
Jenna Kristan, Mark A Malesker, James M Backes, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
July 2, 2019
Alpha-1 Antitrypsin Replacement in Patients With COPD
Adam D Wells, Anna Woods, Daniel E Hilleman, et al.
COPD
|
April 26, 2011
Economic evaluation of a disease management program for chronic obstructive pulmonary disease
Naresh A Dewan, Kathryn L Rice, Michael Caldwell, et al.
Page
of 7